Home » AstraZeneca Acquires Chinese Generic Firm, Fires 1100 Employees
AstraZeneca Acquires Chinese Generic Firm, Fires 1100 Employees
AstraZeneca is all set to increase its footprint in China as the company took one more step in that direction recently by the acquisition of a Chinese generic injectable antibiotics manufacturer.
Beacon Equity Research
Beacon Equity Research
Upcoming Events
-
07May
-
14May
-
30May